SCHEMBL17486347

SCHEMBL17486347

CCC1(CC)OC(CC)(CC)c2cc(-c3ccc(-c4nc(C)cc(-c5ccccc5)n4)cn3)ccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 1/20 0.35
LMNA P02545 2/20 0.35
CYP3A4 P08684 2/20 0.34
KDM4E B2RXH2 2/20 0.34
TP53 P04637 2/20 0.34
MAPT P10636 2/20 0.34
HPGD P15428 2/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
TSHR P16473 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 1/20 0.34
VCP P55072 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
MAP4K4 O95819 1/20 0.33
ABL1 P00519 1/20 0.33
LCK P06239 1/20 0.33
FYN P06241 1/20 0.33
IGF1R P08069 1/20 0.33
LTK P29376 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15614984 0.84 HSD17B1 (0.41) SLC6A9CYP3A4CYP11B1CYP11B2DHODH
SCHEMBL19295151 0.82 MAPT (0.31) LMNAKDM4EMAPTHPGDCYP11B1
SCHEMBL17486116 0.80 LMNA (0.35) LMNAKDM4ETP53MAPTHPGD
SCHEMBL17486297 0.79 LMNA (0.38) LMNAKDM4EMAPTHPGDMEN1
SCHEMBL17486218 0.73 RAB9A (0.40) TP53SMN1; SMN2HSD17B10
SCHEMBL19295154 0.72 MEN1 (0.38) LMNAKDM4EMAPTHPGDRXFP1
SCHEMBL17486300 0.71 MEN1 (0.42) LMNAKDM4EMAPTHPGDTSHR
SCHEMBL17486341 0.71 MEN1 (0.39) LMNAKDM4EMAPTHPGDSMN1; SMN2
SCHEMBL19300460 0.70 MTOR (0.34) LMNAKDM4EMAPTHPGDSMN1; SMN2
SCHEMBL17486029 0.70 RARB (0.44) LMNAKDM4EMAPTHPGDRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3174890-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-03-13 EP disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
WO-2016015815-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2016-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170250353-A1 METAL COMPLEXES SOD1, AP1M1, AP3M1 SLC6A9 1085/4885LMNA 4436/4885CYP3A4 2252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.